振东制药：8月22日召开董事会会议

Group 1 - The company, Zhendong Pharmaceutical, announced on August 24 that its sixth board meeting was held on August 22, 2025, where it reviewed the proposal for cash management using its own funds [1] - For the year 2024, Zhendong Pharmaceutical's revenue composition is as follows: 77.86% from pharmaceutical production and sales, 21.34% from medicinal herb planting, and 0.79% from other businesses [1] - As of the report date, Zhendong Pharmaceutical has a market capitalization of 8.4 billion yuan [1]